April 2013

Cedric Notredame: “We want to understand under what pressure evolves long noncoding RNA”

According to the ENCODE‘s latest update in the human genome there are about 10,000 long sequences of RNA that do not code for any protein. Cedric Notredame’s lab at the Center for genomic Regulation (CRG) tries to detect these molecules not only in humans but also in other species to understand their functionality. Cedric Notredame […]

Cedric Notredame: “We want to understand under what pressure evolves long noncoding RNA” Read More »

Piero Crespo: “We look for site-specific inhibitors and that block protein-protein interactions”

The field of study of Piero Crespo at the Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC) is the regulation of Ras-ERK signals. On April 19, explained the latest developments of their research at a conference framed in IDIBELL seminar series. His work focuses on the study of the mechanisms of Ras regulation in particular

Piero Crespo: “We look for site-specific inhibitors and that block protein-protein interactions” Read More »

High school students discover how research at IDIBELL is

On April 16th science students of the French School of Barcelona visited the IDIBELL to see firsthand how a biomedical research center works. Researchers of the neurometabolic diseases group explained to students the research of a rare disease, the X-linked adrenoleukodistrophy, from basic research, to the investigation with animal models and clinical trial patients. The

High school students discover how research at IDIBELL is Read More »

Identified as responsible for breast and ovarian hereditary cancer three BRCA1 mutations

Researchers of the hereditary cancer research group at the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) conducted a functional and structural study of seven missense variants of the BRCA1 gene concluding that three of these variants are pathogenic, linked to the risk of suffering breast or ovarian cancer. The study

Identified as responsible for breast and ovarian hereditary cancer three BRCA1 mutations Read More »

Laura Valle awarded ‘young researcher in human genetics’

The researcher of the hereditary cancer group at IDIBELL, Laura Valle, has been awarded ‘young researcher in human genetics’ of the Spanish Association of Human Genetics (AEGH). The award was presented on April 12 in Madrid, under the XXVII Congress of the Association, which was held between 10 and 12 April. The award recognizes the

Laura Valle awarded ‘young researcher in human genetics’ Read More »

Rui Benedito: ”We are developing new tools to dissect the molecular mechanisms of angiogenesis”

Researcher Rui Benedito of the National Center for Cardiovascular Research Carlos III (CNIC) Madrid explained his research on the regulation of angiogenesis through the Notch signalling pathway on April 5 at a conference cycle framed within IDIBELL seminars. Angiogenesis is the formation of new blood vessels from pre-existing vessels. Benedito studies this process that normally

Rui Benedito: ”We are developing new tools to dissect the molecular mechanisms of angiogenesis” Read More »

Pathological gambling is associated with age

Researchers of the Psychiatry and Mental Health research group at the Bellvitge Biomedical Research Institute (IDIBELL), in the Bellvitge University Hospital, have shown that patient age influences the onset of pathological gambling disorder and its clinical course. The study results were published in the Journal of Gambling Studies. Personality traits The study was conducted with

Pathological gambling is associated with age Read More »

Kevin M. Ryan: “The goal of a science basic lab should be transfer knowledge to therapeutic improvements for patients”

Cell death is the field of study of the researcher Kevin M. Ryan at The Beatson Institute for Cancer Research in Glasgow (UK). On Friday, March 22 within the cycle of seminars IDIBELL, Ryan explained the latest advances in his research of one of the mechanisms of cell death: autophagy. The goal of the laboratory

Kevin M. Ryan: “The goal of a science basic lab should be transfer knowledge to therapeutic improvements for patients” Read More »

Scroll to Top